Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study ; volume:19 ; number:1 ; day:12 ; month:7 ; year:2019 ; pages:1-9 ; date:12.2019
BMC psychiatry ; 19, Heft 1 (12.7.2019), 1-9, 12.2019
- Creator
-
Lin, An-Sheng
Chan, Hung-Yu
Peng, Ying-Chieh
Chen, Wei J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12888-019-2204-6
- URN
-
urn:nbn:de:101:1-2019110613391427384229
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lin, An-Sheng
- Chan, Hung-Yu
- Peng, Ying-Chieh
- Chen, Wei J.
- SpringerLink (Online service)
Other Objects (12)
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders
An international research agenda for clozapine-resistant schizophrenia
Clozapine improves dizocilpine-induced delayed alternation impairment in rats
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Clozapine-induced agranulocytosis
Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders
An international research agenda for clozapine-resistant schizophrenia
Clozapine improves dizocilpine-induced delayed alternation impairment in rats
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Clozapine-induced agranulocytosis
Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders
An international research agenda for clozapine-resistant schizophrenia
Clozapine improves dizocilpine-induced delayed alternation impairment in rats
Slower clozapine titration is associated with delayed onset of clozapine-induced fever among Japanese patients with schizophrenia
Aripirazole augmentation in clozapine-associated obsessive-compulsive symptoms in schizophrenia
A systematic review of neuroimaging studies of clozapine-resistant schizophrenia
Clozapine-associated Development of Second-onset Obsessive Compulsive Symptoms in Schizophrenia: Impact of Clozapine Serum Levels and Fluvoxamine Add-on
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Clozapine-induced agranulocytosis